|Bid||61.23 x 800|
|Ask||61.24 x 1200|
|Day's range||60.67 - 61.34|
|52-week range||52.05 - 73.86|
|PE ratio (TTM)||24.24|
|Earnings date||25 Jul 2018 - 30 Jul 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||65.53|
Veeva Systems, Tabula Rasa, Teledoc and Evolent are among the medical software names rallying as the health care sector accelerates its move to digital technologies.
Cerner (CERN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
A big federal deal for Cerner and a management shake up at Baidu helped set the tone for early trade Friday.
Veeva (VEEV) strengthens its position by providing the life sciences industry with a streamlined commercial database besides notable technological innovations.
On May 16, IQVIA Holdings’ (IQV) closing price was $99.3, almost 2.9% lower than its closing price on May 15. This fall was attributable to concerns raised by the FDA related to inaccuracies in sales data given to the FDA by IQVIA, which included data about certain opioid drug products. The FDA has been using data from IQVIA to understand the scale of opioid use and to estimate the future requirement of these drugs.
The delay of a major contract contributed to the healthcare technology leader missing its first-quarter revenue forecast.
On a per-share basis, the North Kansas City, Missouri-based company said it had profit of 48 cents. Earnings, adjusted for one-time gains and costs, were 58 cents per share. The results met Wall Street ...
Given the solid prospects in the U.S. medical products industry, here we take a peek at four major Medical Product companies scheduled to report results on May 2.
Cerner's (CERN) HealtheIntent intends to serve 20,000 Medicare patients in Illinois through IRCCO's accountable care organizations.